Results 21 to 30 of about 52,032 (260)

Anticholinergic therapy for acute asthma in children. [PDF]

open access: yes, 2012
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta(2)-agonists) are one of the several medications available for the treatment of acute asthma in ...
Beakes   +49 more
core   +2 more sources

Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis.

open access: yesPLoS ONE, 2021
BackgroundA combination of ipratropium bromide (IB) and salbutamol is commonly used to treat asthma in children and adolescents; however, there has been a lack of consistency in its usage in clinical practice.ObjectiveTo evaluate the efficacy and safety ...
Hongzhen Xu   +6 more
doaj   +1 more source

Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma [PDF]

open access: yes, 2013
Background In acute asthma inhaled beta₂-agonists are often administered by nebuliser to relieve bronchospasm, but some have argued that metered-dose inhalers with a holding chamber (spacer) can be equally effective.
Ba   +70 more
core   +1 more source

Effects of High Flavanol Dark Chocolate on Cardiovascular Function and Platelet Aggregation. [PDF]

open access: yes, 2015
Regular consumption of chocolate and cocoa products has been linked to reduced cardiovascular mortality. This study compared the effects of high flavanol dark chocolate (HFDC; 1064mg flavanols/day for 6 weeks) and low flavanol dark chocolate (LFDC; 88mg ...
Akita   +56 more
core   +1 more source

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]

open access: yes, 2012
An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Altman   +18 more
core   +1 more source

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®) : historical, matched-cohort study of real-life asthma patients [PDF]

open access: yes, 2014
Peer reviewedPublisher ...
Gould, Shuna   +5 more
core   +1 more source

Levosalbutamol as alternative to drugs on the basis of racemic salbutamol: Review of the results of pre-clinical research

open access: yesRegulatory Mechanisms in Biosystems, 2017
The aim of the work is to conduct an analytical review of the results of preclinical studies of levosalbutamol. The review discusses the pharmacodynamic features of the R-stereoisomer of salbutamol in vitro.
A. G. Miroshnichenko   +3 more
doaj   +1 more source

Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine

open access: yesPharmaceutics, 2023
Drug–drug interactions (DDIs) represent a significant concern in healthcare, particularly for patients undergoing polytherapy. DDIs can lead to a range of outcomes, from decreased therapeutic effectiveness to adverse effects. Salbutamol, a bronchodilator
Lara Marques, Nuno Vale
doaj   +1 more source

Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma [PDF]

open access: yes, 2010
Background Formoterol is a long-acting beta(2)-agonist but because it has a fast onset of action it can also be used as a relief medication. Objectives To asses the efficacy and safety of formoterol as reliever therapy in comparison to short-acting ...
Cates, CJ, Welsh, EJ
core   +1 more source

The effects of salbutamol in an experimental model with acute respiratory distress syndrome

open access: yesJournal of Acute Disease, 2012
Objective: To investigate salbutamol effects on histopathologic features of acute respiratory distress syndrome (ARDS). Methods: ARDS was designed in Wistar albino male rats, 250–300 g in weight, by intratracheal instillation of physiological saline ...
Sema Yilmaz   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy